D-Alanine,(3S)-3-hydroxy-N-[(2S)-2-hydroxy-1-oxo-2-[(2R,5R,6R)-tetrahydro-2-hydroxy-6-methyl-5-[(2S)-2-methylbutyl]-2H-pyran-2-yl]propyl]-L-leucyl-(3R)-hexahydro-3-pyridazinecarbonyl-N-hydroxy-L-alanylglycyl-(3S)-hexahydro-3-pyridazinecarbonyl-N-hydroxy-,(6®13)-lactone
| Product Information | |
|---|---|
| Product Number: | AX-CWDH |
| Product Name: | D-Alanine,(3S)-3-hydroxy-N-[(2S)-2-hydroxy-1-oxo-2-[(2R,5R,6R)-tetrahydro-2-hydroxy-6-methyl-5-[(2S)-2-methylbutyl]-2H-pyran-2-yl]propyl]-L-leucyl-(3R)-hexahydro-3-pyridazinecarbonyl-N-hydroxy-L-alanylglycyl-(3S)-hexahydro-3-pyridazinecarbonyl-N-hydroxy-,(6®13)-lactone |
| CAS: | 125228-51-5 |
| MW: | 840.9606 |
| Synonyms: | D-Alanine,(aS,2R,5R,6R)-tetrahydro-a,2-dihydroxy-a,6-dimethyl-5-[(2S)-2-methylbutyl]-2H-pyran-2-acetyl-(3S)-3-hydroxy-L-leucyl-(3R)-hexahydro-3-pyridazinecarbonyl-N-hydroxy-L-alanylglycyl-(3S)-hexahydro-3-pyridazinecarbonyl-N-hydroxy-,(7®2)-lactone (9CI); D-Alanine,erythro-3-hydroxy-N-[2-hydroxy-1-oxo-2-[tetrahydro-2-hydroxy-6-methyl-5-(2-methylbutyl)-2H-pyran-2-yl]propyl]-L-leucyl-D-hexahydro-3-pyridazinecarbonyl-N-hydroxy-L-alanylglycyl-L-hexahydro-3-pyridazinecarbonyl-N-hydroxy-,r-lactone, [2R-[2a,2(S*),5a(S*),6b]]-;13H,22H-Dipyridazino[6,1-f:6',1'-o][1,4,7,10,13,16]oxapentaazacyclononadecine,cyclic peptide deriv.; Antibiotic L 156602; L 156602; PD 124966 |
| EINECS: | |
| Density: | 1.37g/cm3 |
| Melting Point: | |
| Boiling Point: | °Cat760mmHg |
| Flash Point: | °C |
| Solubility: | |
| Risk Codes: | |
| Transport Information:: | |